Efficient treatment of recurrent hepatitis B complications can save lives and money: NHRI researchers

December 9, 2019 Scientists with Taiwan’s National Health Research Institutes (NHRI) and National Taiwan University Hospital, with the support of the Taiwan Cooperative Oncology Group (TCOG), have determined that prophylactic antiviral therapy for lymphoma patients will be essential to optimizing preventative strategies and the allocation of medical resources. In hepatitis…

Continue reading

Frequent drinking associated with risk of head and neck cancer: NHRI study November 25, 2019   Higher frequency and amount of alcohol use are associated with an increased head and neck cancer risk, according to the results of a study conducted by the National Health Research Institutes’ National Institute of…

Continue reading

Do you have social jet lag? Rhythm, a new smartphone app, helps you understand your sleep rhythms

November 18, 2019 A free new smartphone application, Rhythm, developed by Dr. Yu-Hsuan Lin of the National Research Health Institutes, is a breakthrough for measuring sleep patterns that can help people improve their sleep health and consequently their overall quality of life. Its features represent an important advance over what…

Continue reading

Substance in honeybee propolis may be useful in treating prostate cancer: new study

November 11, 2019   Dysregulation of androgen receptor signaling is one of the causes promoting the development of prostate cancer, benign prostate hyperplasia (BPH), and androgenetic alopecia. The prescription drugs for these diseases either block the production of androgen or inhibit the binding between androgen and androgen receptor (AR). However,…

Continue reading

NHRI Taiwan launches G2020 Population Genomics Pilot, partnering with Illumina on an Operational Architecture for Population Genomics

November 6, 2019 Pilot effort will sequence 10,000 genomes by end of 2020, with the goal of embedding genome sequencing in the health system by 2025. TAIPEI: The National Health Research Institutes (NHRI) of Taiwan today announced that it is taking an effort to embed whole genome and exome sequencing…

Continue reading

NHRI’s technology behind a novel vaccine for respiratory syncytial virus was transferred to BioChina, leading to the 2018 Outstanding Tech Transfer Award from the Ministry of Science and Technology

September 2, 2019 (for immediate release) Vaccine research at the National Health Research Institutes (NHRI) of Taiwan has led to an award from the Ministry of Science and Technology for Outstanding Technology Transfer. This helps reconfirm NHRI’s essential role in Taiwan’s biomedicine sector. The technology for a novel vaccine for…

Continue reading

NHRI Transfers Important Biomedical Technology to OriGem for Further Development

June 17, 2019 National Health Research Institutes (NHRI) of Taiwan is pleased to announce the licensing and transfer of two outstanding technologies — “A Microfluidic Dual-well Device for High-throughput Single-cell Capture and Culture” and “Selective Particle Transfer from One Device to Another” — to OriGem Biotech of Taiwan. The transfer…

Continue reading

NHRI licenses DBPR216, an anti-cancer developmental drug candidate, to Taivex Therapeutics Corp.

April 17, 2019 The National Health Research Institutes (NHRI) and Taivex Therapeutics Corp. (Taivex) are pleased to announce the technology transfer of DBPR216, a potential anti-cancer developmental drug candidate, effective April 8. NHRI’s licensing of DBPR216, a multi-targeted tyrosine kinase inhibitor, to Taivex will further the drug’s preclinical and clinical…

Continue reading